A-dopamine

DRUG2 trials

Sponsors

University Hospital, Lille

Conditions

Parkinson Disease

Phase 1

Dopaminergic restauratIon by intraVEntriculaire Administration

CompletedNCT04332276

University Hospital, LilleParkinson Disease

Start: 2020-09-18End: 2024-05-06Updated: 2026-05-14

Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)

CompletedNCT07214285

University Hospital, LilleParkinson Disease

Start: 2025-10-01End: 2025-10-30Updated: 2026-05-22

Related Papers

Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trial.

2025-01-075 citations